RxDoctor Payments Data

Snehal Dalal, MD

Surgery of the Hand · Johns Creek, GANPI 1639120702

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (43.6%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 67.8% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2020 at $7,873 and has fallen 91.0% since, to $709 in 2025.

$19,912in general payments, 2019–2025

Across 90 payments — averaging $221.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$13K
  • Zimmer Biomet$4K
  • Catalyst Orthoscience$682
  • Bioventus LLC$490
  • Johnson & Johnson$442
  • Stryker$314
  • plus $809 from 12 others
$32,700in research payments, 2019–2025

Across 1 payment — averaging $32,700 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$33K

What the payments were for

  • Consulting fees$8,67244%
  • Speaking & faculty fees$5,63128%
  • Travel & lodging$2,12411%
  • Food & beverage$3,48417%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few surgery of the hand providers in Georgiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$198,533
Medicare patients
332
Services billed
1,874

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium17$1,075
Ibuprofen134$910
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen65$668
Meloxicam204$661
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen72$610
Ondansetron Hcl94$406
Tramadol Hcl90$213
Methylprednisolone30$125

Paid to pharmacies, not to this prescriber.

Other surgery of the hand in Johns Creek

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →